BVF GP HOLDINGS LLC
CIK 1803809 · last filed 2026-06-23
BVF GP HOLDINGS LLC is a corporate insider who has filed 19 SEC Form 4 insider transactions across 9 companies since 2020. The most recent filing, for OLMA, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$766.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $264.7M across reported positions. The firm reports its address in San Francisco, CA. 159 SEC filings were submitted jointly with BVF I GP LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$264.70M
9
19
$766.16M
Filer Profile
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | Director | 2,755,533 | $10.22 | $28.16M | $225.71M | 4 | 2026-06-23 |
| KYMR | Director | 294,632 | $114.96 | $33.87M | $154.35M | 3 | 2024-08-22 |
| MLTX | Director | 11,265,678 | $12.51 | $140.93M | $0 | 1 | 2023-06-12 |
| XOMA Royalty Corp (XOMAP) Delisted | Director | 1,818,637 | $24.98 | $45.43M | $4.09M | 2 | 2023-05-19 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 2,969,742 | $2.65 | $7.87M | $218.59M | 1 | 2022-06-06 |
| Merus N.V. (MRUS) Delisted | 10%+ Owner | 3,803,152 | $90.00 | $342.28M | $99.89M | 3 | 2021-04-01 |
| IDYA | 1,642,186 | $37.59 | $61.73M | $8.54M | 2 | 2021-02-04 | |
| XOMA Royalty Corp (XOMA) Delisted | 10%+ Owner | 171,336 | $40.17 | $6.88M | $54.99M | 2 | 2020-12-15 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | 10%+ Owner | 541,116 | $38.00 | $20.56M | $1.2K | 1 | 2020-09-24 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2024-08-22 | KYMR | Buy (P) | — | $0 | EDGAR |
| 2023-09-14 | OLMA | Mixed | +16,054,880 | $148.18M | EDGAR |
| 2023-06-12 | MLTX | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | XOMA Royalty Corp (XOMAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-13 | KYMR | Buy (P) | +410,070 | $12.51M | EDGAR |
| 2022-09-27 | XOMA Royalty Corp (XOMAP) Delisted | Buy (P) | +246,420 | $4.09M | EDGAR |
| 2022-08-23 | KYMR | Buy (P) | +5,455,250 | $141.84M | EDGAR |
| 2022-06-14 | OLMA | Buy (P) | +2,000,000 | $8.07M | EDGAR |
| 2022-06-06 | Repare Therapeutics Inc. (RPTX) Delisted | Buy (P) | +18,369,580 | $218.59M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.